Scientist_TubeAsclepiX Therapeutics technology has numerous benefits compared to conventional anti-angiogenic therapies including:

  • Multimodality that blocks both VEGF-mediated and non-VEGF-mediated angiogenesis
  • Regression of angiogenic vessels beyond inhibition of new growth, which could “turn back the clock” on angiogenic diseases
  • Controlled delivery that can reduce the frequency of doses and improve patient safety
  • Compounds that significantly inhibit vascular permeability and leakage
  • A platform of peptide drugs that can be easier and cheaper to manufacture and deliver than protein drugs.